Patient Centric Sampling: Bringing the Clinical Trials to the Patient

Stephanie Cape, PhD, Head of R&D, Scientific Affairs, Labcorp Drug Development

Stephanie Cape, PhD heads Research and Development within Scientific Affairs at Labcorp Drug Development. The Scientific Affairs team is focused on positioning the laboratories with technologies and expertise to support the rapidly evolving needs of pharmaceutical testing.

Over the past 12 years with Labcorp Drug Development, Dr. Cape has served in a variety of scientific leadership roles, been actively engaged in a number of industry groups and grown a particular interest in enabling new technologies. She has held multiple leadership positions within the American Association of Pharmaceutical Sciences, serves as a subject-matter expert for the Bioanalysis Zone, is a member of the Bioanalysis journal editorial board, sits on the advisory board for the Madison College biotechnology program and is an active contributor to the Global CRO Council. Dr. Cape is particularly engaged in patient centric sampling and contributes to the Global Patient Centric Sampling Interest Group as well as the AAPS Microsampling and Patient Centric Sampling team.

Dr. Cape has authored over 30 peer reviewed publications including four book chapters and contributed many posters and presentations. She received her BS in chemistry from University of IL- Urbana/Champaign in 2003 and her PhD in analytical chemistry from the University of Wisconsin- Madison in 2007.

Bradley Collier, PhD, Research and Development Scientist, Labcorp

Bradley Collier, PhD received his doctorate in biomedical engineering from Texas A&M University in 2013. Holding several research positions, he has contributed to the development of a variety of analytical and microfluidic biotechnologies. Since 2017, Dr. Collier has been working for Labcorp where he currently investigates various novel capillary blood microsampling solutions for clinical measurements.

Satya N. Narla, PhD, NRCC(CC), Associate Director, Safety Testing Department, Labcorp Drug Development

Satya Narla, PhD is Associate Director for the safety testing team at Labcorp Drug Development’s Indianapolis central laboratory site. She joined Labcorp in January 2016 as Senior Scientist in Immunology and was promoted to Associate Director of Operations for the Safety Testing Department in 2019. Dr. Narla received her PhD in clinical bio-analytical chemistry from Cleveland State University in 2013 and completed her post-doctoral training as clinical chemist at the Medical University of South Carolina in 2015 prior to joining Labcorp. In her current role she is responsible for overall operational and technical management of the Safety Testing Department, including routine chemistry, immunology, hematology and urinalysis testing areas.

Gregory Sommer, PhD, Technical Director, Research and Development, Labcorp

Greg Sommer, PhD serves as Technical Director of R&D at Labcorp, overseeing the design, validation and deployment of new decentralized liquid microsample collection technologies. Dr. Sommer joined Labcorp in 2021 following Labcorp’s acquisition of Sandstone Diagnostics, Inc. — a consumer healthcare and diagnostics technology company he co-founded in 2012. He received his PhD in Mechanical Engineering from the University of Michigan in 2008, and previously served as a Staff Scientist in Biodefense Technologies at Sandia National Laboratories from 2008-2012.